Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 8Thoracic 2Sarcoma 2Lymphoid 1Head & Neck 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Head and Neck Neoplasms 2103Squamous Cell Carcinoma of Head and Neck 1654Nasopharyngeal Carcinoma 517Thyroid Neoplasms 478Carcinoma, Non-Small-Cell Lung 438Breast Neoplasms 315Mouth Neoplasms 312Neoplasms 309Melanoma 299Oropharyngeal Neoplasms 285Colorectal Neoplasms 274Lung Neoplasms 248Carcinoma, Squamous Cell 240Neoplasm Metastasis 235Ovarian Neoplasms 228Uterine Cervical Neoplasms 204Stomach Neoplasms 195Salivary Gland Neoplasms 192Laryngeal Neoplasms 192Nasopharyngeal Neoplasms 189Carcinoma, Renal Cell 183Esophageal Neoplasms 179Pancreatic Neoplasms 176Prostatic Neoplasms 158Sarcoma 142Triple Negative Breast Neoplasms 136Urinary Bladder Neoplasms 135Recurrence 128Endometrial Neoplasms 124Hypopharyngeal Neoplasms 121

Interventions

Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Nervous System Neoplasms × Head & Neck × Clear all
NCT00437372 2025-05-02

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Thomas Jefferson University

Phase 1 Completed
39 enrolled
GynecologicHead & NeckThoracic

Head and Neck Neoplasms, Neoplasms, Nervous System Neoplasms, Pelvic Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡